Thanks Mike. I know I speak for all colleagues in welcoming you to TriNet. During 2023, TriNet continued to excel in the areas we controlled. We accelerated new sales growth, we kept customers longer, and we managed our expenses prudently while still investing in our growth and digital transformation. As it relates to capital, we published our financial policy and capital allocation approach to our investors, we issued $400 million of bonds, and renegotiated and borrowed on our revolving line of credit, and we repurchased over $1.1 billion of our stock. This execution reflects the continued maturation of the company's financial management. We've built towards these actions over several years, having negotiated borrowing terms, issuing long-term debt, and enhancing our forecasting capabilities. To top it off, we've just announced today the initiation of a quarterly dividend of $0.25 per share. The initiation of our dividend signifies two things for TriNet. One, we manage a business that generates significant and predictable corporate cash flows, which enable the funding of a dividend. And two, with that dividend, we now have diversified capital return options for shareholders consistent with our financial policy. Now, let's dive into our fourth quarter and full year financial performance in greater detail. Total revenues grew 2% year-over-year for the fourth quarter and 1% for the year, in line with our guidance range. Total revenues performance for the year was largely characterized by the offsetting impacts from lower average WSE volumes and higher rate and mix contributions. Our lower overall average WSE volumes was due to workforce reductions in some verticals of our installed customer base and the lack of hiring in others throughout 2023. This was a result of the challenging economic environment, particularly in the technology sector. Professional service revenues in the quarter and for the full year were flat year-over-year, in line with our guidance. Consistent with our total revenues performance, professional services revenues were impacted by lower volumes, largely driven by the lack of customer hiring, offset by modest rate increases in HRIS performance. Our HRIS performance for the year was driven by three factors; first, the renegotiation of certain broker arrangements during the third quarter; second, our success at lifting price to properly reflect the value of our HRIS services provided. And finally, our HRIS performance benefited from a full year of revenue in 2023 when compared with the timing of our acquisition in February of 2022. Regarding WSE volume, we finished the year with approximately 348,000 WSEs, slightly down year-over-year. This reflected a continuation of the trends we experienced throughout 2023. We saw net positive contributions from new sales. Customer hiring was significantly lower than historical levels, but modestly positive and retention remains strong. Last quarter, we introduced a broader WSE definition, which reflects those receiving PEO services and using the value of our PEO platform. As we build our new platform and think through the opportunities to drive revenue by delivering value to an even broader base, we will continue to work through our existing categorizations and adjust as appropriate. We do earn revenue on each of these WSEs at varying levels as we refine our processes and expand our product offerings, the incremental service fees we receive on WSEs will be additive to PSR. The recategorization of WSEs added just under 12,000 to our final tally. On a legacy apples-to-apples comparison, we finished the fourth quarter with 336,000 WSEs, down 4% year-over-year and flat sequentially. For the fourth quarter, our insurance cost ratio was approximately 87% lower than our forecasted range for the quarter of 88% to 92%. For the full year, our insurance cost ratio was 84.3%, slightly lower than our latest guidance range for the year of 84.5% to 85.5%. The lower insurance cost ratio in the quarter reflected an uptick in health care utilization, particularly in November, more than offset by favorable workers' compensation prior period claims development. This workers' compensation trend was consistent with our full year experience. Turning to operating expenses in the quarter. We continue to prudently manage our expenses in response to the challenging economic environment. We saw that our plant hiring would remain choppy throughout the quarter, and therefore, we began to scale back or cancel some of our discretionary hiring and project spending, while still ensuring we were investing in critical go-to-market capabilities. The recalibration of our expense run rate strengthens our cash flow position as we wait for our clients to resume hiring. As such, for the fourth quarter, operating expenses declined 6% year-over-year. And for the full year, operating expenses grew a modest 2%. Now, let's move on to earnings per share. Fourth quarter GAAP net income per diluted share exceeded the top end of our guidance by $0.31 to $1.31, up 68% year-over-year. Our fourth quarter earnings outperformance versus our guidance was driven by expense favorability and the workers' compensation performance I just discussed. This brought full year GAAP net income per diluted share to $6.56, up 17% when compared to 2022. Fourth quarter adjusted net income per diluted share also exceeded the high end of guidance by $0.27 to $1.60, up 44% year-over-year. This brought our full year adjusted net income per share to $7.81, up 10% versus 2022, exceeding the top end of guidance by $0.26. Turning to capital allocation. Today, we announced the institution of a quarterly dividend of $0.25. The record date will be April 1st, payable on April 22nd. With the institution of our new dividend, TriNet capped off an extraordinary year as it relates to our capital allocation strategy. Our capital priorities remain unchanged; we will always invest in our business for growth, we will explore accretive M&A, and we will return capital to shareholders through both share repurchases and our newly instituted dividend. During 2023, we publicly articulated our financial policy, which included our commitment to manage our business at a leverage ratio of 1.5 times to 2 times adjusted EBITDA and return up to 75% of free cash flow to investors. For the year, we generated $539 million in corporate operating cash flow, an 8% year-over-year increase. and we generated $697 million in adjusted EBITDA, representing 1% year-over-year growth. In summary, we exit 2023 in a strong financial position. Now, let's turn to our 2024 first quarter and full year outlook, where I will provide both GAAP and non-GAAP guidance. In the first quarter of 2024, we expect total revenues to grow in a range of 0% to 3% year-over-year and professional service revenues to grow in a range of 2% to 8% year-over-year. Our first quarter revenue growth guidance includes contributions from new sales growth and strong retention, offset by the limited contribution from CIE as weak customer hiring trends persist. In Q1, we are planning for health care utilization to increase over recent experience. This will result in an insurance cost ratio between 82.5% to 86.5%, reflecting our seasonally lower ratios at the beginning of each year. This brings our estimate of first quarter GAAP net income per diluted share to be in the range of $1.81 to $2.55 per share and first quarter adjusted net income per diluted share to be in the range of $2.10 to $2.85 per share. Regarding our full year 2024 guidance, we are forecasting our year-over-year total revenues to be in the range of down 1% to up 4% with our professional service revenues to grow in the range of 1% to 5% year-over-year. We expect our insurance cost ratios to follow seasonal patterns and reflect favorable cost ratios in the first and second quarters as participants work through deductibles. we then foresee a return to higher insurance cost ratios in the third and fourth quarters as deductibles are exhausted and when pooling limits reset in October. We should continue to benefit from strong workers' compensation performance. These trends bring our full year insurance cost ratio forecast to be in the range of 86.5% to 88.5%. This ICR projection is about 2 to 4 points higher than our 2023 result, reflecting increased health care utilization, higher provider costs, particularly for outpatient services, and higher pharmaceutical pricing as we see continued adoption of GLP-1s as an example. We will watch this closely throughout 2024 and assess any refinements needed as we determine quarterly pricing changes. Regarding our expectation for operating expenses, we will continue to manage our expenses prudently. As such, we expect a modest low single-digit increase in operating expenses for the year. Given these anticipated trends, we expect full year GAAP net income per diluted share to be in the range of $4.57 to $6.08 per share and adjusted net income per diluted share to be in the range of $5.80 to $7.35 per share. Our guidance for adjusted net income per diluted share includes a net benefit of between $0.25 and $0.30 per share at the midpoint versus a benefit of $0.13 per share last year as a result of our 2023 share repurchases. For 2024, we're assuming in our guidance a level of share repurchases that will continue to offset normal dilution arising from stock compensation. Before I pass the call back to Burton for his concluding remarks, I would like to take a moment and thank him for the leadership he has provided TriNet over the years and for the successful partnership we forged over the last three and a half of those. We accomplished a lot in such a short period of time. Your vision for building TriNet into an enduring company redefined what a PEO could be and created over $6 billion of enterprise value during your tenure. I know I speak for all TriNet colleagues when I wish you nothing but happiness in your well-deserved retirement. Burton?